Fifty-Year-Old Urine Drug Tests Are Misleading Doctors and Harming Patients, Experts Warn
Physicians warn that decades-old immunoassay-based urine drug tests routinely produce false results that mislead clinicians and harm patients, calling for ...
Tag: Opioid Use Disorder
Ibogaine Shows Promise Against Addiction, but Cardiac Risks Loom Large
A new review in Advances in Therapy finds that the psychedelic alkaloid ibogaine shows broad anti-addictive potential across opioid, stimulant, ...
Addiction Training Cuts Physician Stigma by Building Confidence, National Survey Finds
A nationally representative survey of 855 U.S. primary care and emergency department physicians finds that addiction training reduces provider stigma ...
Hospital Algorithm Flags Thousands, Yet Only a Fraction Start Buprenorphine
A two-year hospital trial screening effort generated 9,140 flagged records but enrolled only 23 patients on buprenorphine, exposing both algorithmic ...
Rock Bottom Does Not Drive Recovery, Johns Hopkins Study of Opioid Addiction Finds
A Johns Hopkins qualitative study of 20 people recovering from opioid use disorder finds that only 10 percent were motivated ...
Colorado Bets $4.9 Million on Rural Pharmacies to Close Its Widening Healthcare Gap
A $4.94 million first-year federal award launches Colorado STREAM, a five-year, nearly $25 million initiative connecting rural pharmacies with treatment ...
Most U.S. Pharmacists Back Methadone in Pharmacies, but Barriers Loom Large, Nationwide Survey Finds
A nationwide survey of 585 U.S. pharmacists finds majority confidence in partnering with opioid treatment programs to dispense methadone, despite ...
Doctors Reveal Why Opioid Care Fails Indigenous Patients in Canada
A qualitative study of 13 Canadian physicians reveals that fragmented systems, inconsistent training, and colonial structural forces, not just prescribing ...
Exploring Incentives for Buprenorphine Treatment in Family Medicine
In recent years, the opioid crisis has escalated into a public health emergency, with millions of individuals affected by opioid ...
Medication for Opioid Disorder Enhances Patient Discharge Rates
In recent years, the escalating opioid crisis has emerged as one of the most pressing public health challenges. An increasing ...
Rapid Low-Dose Buprenorphine Induction in Fentanyl Users
A groundbreaking advancement in the field of addiction treatment has emerged with the introduction of a simplified, rapid low-dose buprenorphine ...
Innovative Remote Program for Opioid Use Disorder Pilot Test
A novel approach to combat one of the most pressing public health crises of our time has recently emerged, revealing ...
Enhancing Buprenorphine Access Through Library Telehealth
In an increasingly technology-driven world, the intersection of healthcare accessibility and telehealth has become a focal point for innovations aimed ...
Evidence Lacking: Genetic Testing’s Role in Assessing Opioid Misuse Risk
Opioid misuse remains one of the most pressing public health challenges in the United States, representing a multi-faceted crisis that ...
Racial, economic barriers hinder access to medicine for treating opioid use disorder
PORTLAND, Ore. – Patients with a prescription for an opioid use disorder medication may have a tough time getting it ...
Secret shopper study sheds light on barriers to opioid treatment for women
After a 2020 Vanderbilt University Medical Center study showed women have a difficult time accessing treatment for opioid use disorder ...
